Franklin Gray and White Blog

Pfizer to Pay $894 Million to Settle Celebrex, Bextra Lawsuits

From Bloomberg.com, Pfizer has agreed to settle many of the the pending lawsuits against the company claiming injuries from the use of its products, Celebrex and Bextra.  Although this settlement agreement has yet to be approved by any Court, Pfizer announced that it is prepared to pay approximately $894 million to resolve over 90% of the pending lawsuits regarding these products.

The lawsuits alleged that painkillers Celebrex and Bextra caused heart attacks and strokes. 

The law firm of Franklin Gray & White has experience in the litigation of national class actions, like the one described above.  For more information on class action litigation, please see here.  If you or a loved one believe that you have been injured by the use of a prescription, over-the-counter, or otherwise recalled medication, please contact one of the attorneys at Franklin Gray & White for a free consultation.